These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3083759)

  • 1. [Ranitidine inhibition of gastric secretion stimulated by pentagastrin. Results in 30 cases of duodenal ulcer].
    Toulet J; Pagniez R; Viteau JM; Rousselet J; Bosc F; Vienne JL
    Ann Gastroenterol Hepatol (Paris); 1986; 22(1):9-14. PubMed ID: 3083759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition by a 2-pyridyltetrahydrothiophene derivative (40749 RP) of gastric secretion stimulated by pentagastrin. Results in 30 duodenal ulcer patients].
    Toulet J; Pagniez R; Viteau JM; Bosc F; Vienne JL
    Gastroenterol Clin Biol; 1984 Feb; 8(2):157-61. PubMed ID: 6698354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamics of gastric acid inhibition by ranitidine in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Digestion; 1981; 22(3):119-25. PubMed ID: 6116636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pirenzepine on basal gastric acid and pepsin secretion and on secretion stimulated with graded doses of pentagastrin in duodenal ulcer patients.
    Meneghelli UG; Troncon LE
    Braz J Med Biol Res; 1988; 21(4):781-9. PubMed ID: 3149202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer.
    Hirschowitz BI
    Gastroenterology; 1984 May; 86(5 Pt 1):843-51. PubMed ID: 6423436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of various secretory inhibitors on peptic activity.
    Gabryelewicz A; Laszewicz W; Sarosiek J
    Scand J Gastroenterol Suppl; 1980; 66():79-85. PubMed ID: 6264587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in total pepsin activity and pepsinogen I in human sera under stimulation and inhibition of gastric acid secretion.
    Schumann KM; Massarrat S
    Hepatogastroenterology; 1991 Dec; 38 Suppl 1():33-6. PubMed ID: 1823064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics and duration of action of ranitidine on gastric secretion and its effect on pancreatic secretion in duodenal ulcer patients.
    Konturek SJ; Obtułowicz W; Kwiecień N; Kopp B; Oleksy J
    Scand J Gastroenterol Suppl; 1981 Jun; 69():91-9. PubMed ID: 6119789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basal and pentagastrin stimulated acid secretion in duodenal ulcer subjects before and after Helicobacter pylori eradication: a 12-month follow-up study.
    Louw JA; Young GO; Lucke W; Bridger S; Winter TA; Marks IN
    Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):363-7. PubMed ID: 9789128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of ranitidine, a new histamine H2-receptor antagonist, on secretagogue-stimulated gastric secretion in Heidenhain pouch dogs (author's transl)].
    Ohtsuki H; Okabe S
    Nihon Yakurigaku Zasshi; 1981 Dec; 78(6):539-47. PubMed ID: 6120885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
    Holloway RH; Kuljian B; Eshelman F; McCallum RW
    Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of pentagastrin-stimulated gastric acid secretion by graded intraduodenal administration of oleic acid in man.
    Kihl B; Olbe L
    Scand J Gastroenterol; 1981; 16(1):121-8. PubMed ID: 7233077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aspects of the effect of metiamide on pentagastrin-stimulated and basal gastric secretion of acid and pepsin in man.
    Thjodleifsson B; Wormsley KG
    Gut; 1975 Jul; 16(7):501-8. PubMed ID: 1098968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of basal acid, chloride, and pepsin secretion in duodenal ulcer by graded doses of ranitidine and atropine with studies of pharmacokinetics of ranitidine.
    Hirschowitz BI; Danilewitz M; Molina E
    Gastroenterology; 1982 Jun; 82(6):1314-26. PubMed ID: 6279466
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of ranitidine on gastric acid and pepsin secretion following sham feeding.
    Müller-Lissner SA; Sonnenberg A; Eichenberger P; Blum AL
    Scand J Gastroenterol Suppl; 1981 Jun; 69():27-31. PubMed ID: 6119779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of ranitidine on the content of glyceroglucolipids in gastric secretion of patients with gastric and duodenal ulcer.
    Sarosiek J; Slomiany BL; Slomiany A; Gabryelewicz A
    Scand J Gastroenterol; 1984 Jul; 19(5):650-4. PubMed ID: 6089304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do ranitidine and nizatidine influence pepsin secretion?
    Vianello F; Tessaro P; Di Mario F; Dal Santo PL; Vio A; Plebani M; Burlina A; Naccarato R
    Acta Gastroenterol Belg; 1988; 51(2):154-8. PubMed ID: 2906777
    [No Abstract]   [Full Text] [Related]  

  • 18. Acid and pepsin responses to graded doses of pentagastrin in duodenal and corporeal gastric ulcer patients before and after selective proximal vagotomy.
    Emås S; Aly A
    Am J Surg; 1985 Nov; 150(5):543-9. PubMed ID: 3933370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastric acid secretion and plasma gastrin during short-term treatment with omeprazole and ranitidine in duodenal ulcer patients.
    Lazzaroni M; Sangaletti O; Bianchi Porro G
    Hepatogastroenterology; 1992 Aug; 39(4):366-70. PubMed ID: 1427586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.
    de Gara CJ; Burget DW; Silletti C; Hunt RH
    Am J Gastroenterol; 1987 Jan; 82(1):36-41. PubMed ID: 3099564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.